Diabetes and Multiple Long-term Conditions: A Review of Our Current Global Health Challenge

Author:

Khunti Kamlesh1ORCID,Chudasama Yogini V.1ORCID,Gregg Edward W.2ORCID,Kamkuemah Monika3,Misra Shivani45ORCID,Suls Jerry6,Venkateshmurthy Nikhil S.78,Valabhji Jonathan49

Affiliation:

1. 1Diabetes Research Centre, Leicester General Hospital, University of Leicester, Leicester, U.K.

2. 2School of Population Health, Royal College of Surgeons in Ireland University of Medicine and Health Sciences, Dublin, Ireland

3. 3Innovation Africa and Department of Architecture, Faculty of Engineering, Built Environment and Information Technology, University of Pretoria, Pretoria, South Africa

4. 4Division of Metabolism, Digestion and Reproduction, Imperial College London, London, U.K.

5. 5Department of Diabetes and Endocrinology, St Mary’s Hospital, Imperial College Healthcare NHS Trust, London, U.K.

6. 6Institute for Health System Science, Feinstein Institutes for Medical Research Northwell Health, New York, NY

7. 7Public Health Foundation of India, New Delhi, India

8. 8Centre for Chronic Disease Control, New Delhi, India

9. 9Department of Diabetes and Endocrinology, St Mary’s Hospital, Imperial College Healthcare NHS Trust, London, U.K.

Abstract

Use of effective treatments and management programs is leading to longer survival of people with diabetes. This, in combination with obesity, is thus contributing to a rise in people living with more than one condition, known as multiple long-term conditions (MLTC or multimorbidity). MLTC is defined as the presence of two or more long-term conditions, with possible combinations of physical, infectious, or mental health conditions, where no one condition is considered as the index. These include a range of conditions such as cardiovascular diseases, cancer, chronic kidney disease, arthritis, depression, dementia, and severe mental health illnesses. MLTC has major implications for the individual such as poor quality of life, worse health outcomes, fragmented care, polypharmacy, poor treatment adherence, mortality, and a significant impact on health care services. MLTC is a challenge, where interventions for prevention and management are lacking a robust evidence base. The key research directions for diabetes and MLTC from a global perspective include system delivery and care coordination, lifestyle interventions and therapeutic interventions.

Funder

National Institute for Health Research

Fogarty International Center of the National Institutes of Health

Applied Research Collaboration East Midlands

NIHR Global Centre for MLTC

NIHR Leicester Biomedical Research Centre (BRC) Wellcome Trust

Publisher

American Diabetes Association

Subject

Advanced and Specialized Nursing,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference100 articles.

1. Key global findings 2021, 2021. Accessed 20 April 2023. Available from https://diabetesatlas.org/

2. Multimorbidity: clinical assessment and management: NICE guideline [NG56], 2016. Accessed 20 April 2023. Available from https://www.nice.org.uk/guidance/NG56

3. Adapting clinical guidelines to take account of multimorbidity;Guthrie;BMJ,2012

4. The impact of comorbid chronic conditions on diabetes care;Piette;Diabetes Care,2006

5. Older people with social care needs and multiple long-term conditions: NICE guideline [NG22], 2015. Accessed 20 April 2023. Available from https://www.nice.org.uk/guidance/ng22/chapter/Recommendations-for-research

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3